Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MAZE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
39 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 12 days ago
Red flags: 0
161 filers reported a long position in MAZE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $150.2M | 5M | +10.2% |
| TRV GP IV, LLC | $133.5M | 4.5M | Unchanged |
| ARCH Venture Management, LLC | $123M | 4.1M | Unchanged |
| Deep Track Capital, LP | $111.4M | 3.7M | +7.3% |
| BlackRock, Inc. | $104.5M | 3.5M | +36.3% |
| Jupiter Topco LLC | $101.8M | 3.4M | — |
| T. Rowe Price Investment Management, Inc. | $77.7M | 2.6M | New |
| Logos Global Management LP | $57.7M | 1.9M | +56.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $53.1M | 1.8M | +23.9% |
| a16z Capital Management, L.L.C. | $50.8M | 1.7M | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.